Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Moon Lake Immunotherapeutics Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $721 Billion
- Q3 2024
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 229,029 shares of MLTX stock, worth $10.5 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
229,029
Previous 228,803
0.1%
Holding current value
$10.5 Million
Previous $10.1 Billion
14.78%
% of portfolio
1.6%
Previous 1.64%
Shares
4 transactions
Others Institutions Holding MLTX
# of Institutions
127Shares Held
58.2MCall Options Held
102KPut Options Held
75.9K-
Bvf Inc San Francisco, CA21.8MShares$997 Million29.25% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$389 Million28.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$127 Million1.66% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.56MShares$117 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.27MShares$104 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.69B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...